TP53 co-mutations increase risk of recurrence in EGFR-mutated stage I lung adenocarcinoma
European Journal of Cancer · 2025
DOI: 10.1016/j.ejca.2025.115622 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift European Journal of Cancer, 2025. Verfasst von Filippo Tommaso Gallina und 16 weiteren Autor:innen. Beteiligte Einrichtung: Division of Thoracic Surgery, McGill University Health Centre, Montreal, QC, Canada; Thoracic Surgery Unit, IRCCS "Regina Elena" National Cancer Inst…. Hauptthemen laut MEDLINE: Tumor Suppressor Protein p53, Mutation, Lung Neoplasms, Neoplasm Recurrence, Local. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 32 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Thoracic Surgery, McGill University Health Centre, Montreal, QC, Canada; Thoracic Surgery Unit, IRCCS "Regina Elena" National Cancer Institute, Rome, Italy; Tumor Immunology and Immunotherapy Unit, IRCCS "Re…
- Department of Experimental Medicine, Sapienza University, Rome, Italy; Division of Medical Oncology 2, IRCCS "Regina Elena" National Cancer Institute, Rome, Italy.
- Thoracic Surgery Unit, IRCCS "Regina Elena" National Cancer Institute, Rome, Italy.
- Pathology Unit, IRCCS "Regina Elena" National Cancer Institute, Rome, Italy.
- Division of Medical Oncology 2, IRCCS "Regina Elena" National Cancer Institute, Rome, Italy.
- Division of Thoracic Surgery, McGill University Health Centre, Montreal, QC, Canada.
Zitieren
APA
Gallina, F. T., Marinelli, D., Tajè, R., Visca, P., Cecere, F. L., Landi, L., Buglioni, S., Forcella, D., Melis, E., Najmeh, S., Rayes, R., Cools-Lartigue, J., Camilleri-Broët, S., Fiset, P. O., Ferri, L., Cappuzzo, F., & Spicer, J. (2025). TP53 co-mutations increase risk of recurrence in EGFR-mutated stage I lung adenocarcinoma. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2025.115622
Vancouver
Gallina FT, Marinelli D, Tajè R, Visca P, Cecere FL, Landi L, et al. TP53 co-mutations increase risk of recurrence in EGFR-mutated stage I lung adenocarcinoma. European Journal of Cancer. 2025. doi:10.1016/j.ejca.2025.115622
BibTeX
@article{Gallina2025,
author = {Gallina, Filippo Tommaso and Marinelli, Daniele and Tajè, Riccardo and Visca, Paolo and Cecere, Fabiana Letizia and Landi, Lorenza and Buglioni, Simonetta and Forcella, Daniele and Melis, Enrico and Najmeh, Sara and Rayes, Roni and Cools-Lartigue, Jonathan and Camilleri-Broët, Sophie and Fiset, Pierre-Olivier and Ferri, Lorenzo and Cappuzzo, Federico and Spicer, Jonathan},
title = {TP53 co-mutations increase risk of recurrence in EGFR-mutated stage I lung adenocarcinoma},
journal = {European Journal of Cancer},
year = {2025},
doi = {10.1016/j.ejca.2025.115622}
}
EUVIMED